Glaxo Ordered to End Avandia Drug Trial Enrollment

more+

less-

7/23/2010

Robert Kraft Contact

Send

The Food and Drug Administration has ordered GlaxoSmithKline to stop enrolling people in a controversial clinical trial comparing diabetes drugs, and to notify more than 1,300 people already undergoing tests that they may be at greater risk for heart attacks because they have taken Avandia.

Please see full article below for more information.

Download PDF[87KB]
Download Word[91KB]
Email
Report

LOADING PDF: If there are any problems, click here to download the file.

Published In: Administrative Law Updates, Health Law Updates, Personal Injury Updates, Products Liability Updates

Send Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.